The Impact of Clinical Pharmacist in the Identification and Management of Treatment Related Problems in the Surgery Ward

NCT04941820 | Completed

• 1 other identifier: 80/2019/1943
• Study Type: interventional
• Target: 100
• Locations: 1 country
• Sites: 1

Brief Summary

Patients in the surgery ward are at risk of morbidity and mortality from various types of treatment-related problems (TRPs). The primary aim of this study is to assess the impact of the clinical pharmacist in the identification and management of TRPs in the surgery ward.

Conditions

Surgical Patients

Keywords

clinical pharmacist; general surgical ward; RCT; SICU

Outcome Measures

Primary Outcomes (3)

• Acceptance rate of clinical pharmacist's recommended interventions

  (Number of recommendations accepted by surgeons) / (total number of recommendations submitted to surgeons by the clinical pharmacist) \*100

  19-week

• Implementation rate of clinical pharmacist's recommended interventions

  (Number of recommendations implemented by surgeons and patients) / (total number of recommendations submitted to surgeons and patients by the clinical pharmacist) \*100

  19-week

• The impact of the clinical pharmacist on the identification and management of TRPs in the surgery ward

  Measured by comparing the means of differences in the number of TRPs identified at baseline and at the time of short-term follow-up in the intervention and usual care groups

  19-week

Secondary Outcomes (1)

• Surgeons' attitudes and satisfaction towards the provided clinical pharmacy services

  19-week

Study Arms (2)

Clinical pharmacist intervention + usual care arm

EXPERIMENTAL

Patients in the clinical pharmacist intervention + usual care arm received the clinical pharmacist intervention as well as usual care provided by the surgical team

Other: clinical pharmacist intervention

Usual care arm (Control arm)

NO INTERVENTION

Patients in the control arm received usual care by the surgical team without a coordinated contribution from the clinical pharmacist

Interventions

clinical pharmacist intervention OTHER

clinical pharmacist intervention

Clinical pharmacist intervention + usual care arm

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Admission for elective, urgent, or emergency surgery
• age 18 years or older
• Expected length of stay of 3 days or more in the general surgical ward or the SICU

You may not qualify if:

• Pregnancy, breastfeeding, drug or alcohol abuse, active malignancy, or admission for plastic surgery

Sponsors & Collaborators

• University of Jordan: lead

Study Sites (1)

University of Jordan

Amman, Jordan

Location

Related Publications (4)

• AbuRuz SM, Bulatova NR, Yousef AM. Validation of a comprehensive classification tool for treatment-related problems. Pharm World Sci. 2006 Aug;28(4):222-32. doi: 10.1007/s11096-006-9048-0. Epub 2006 Oct 26.

  PMID: 17066238 BACKGROUND

• Basheti IA, Ayasrah SM, Ahmad M. Identifying treatment related problems and associated factors among hospitalized post-stroke patients through medication management review: A multi-center study. Saudi Pharm J. 2019 Feb;27(2):208-219. doi: 10.1016/j.jsps.2018.10.005. Epub 2018 Oct 19.

  PMID: 30766431 BACKGROUND

• Bilal AI, Tilahun Z, Beedemariam G, Ayalneh B, Hailemeskel B, Engidawork E. Attitude and satisfaction of health care providers towards clinical pharmacy services in Ethiopia: A post-deployment survey. J Pharm Policy Pract. 2016 Mar 8;9:7. doi: 10.1186/s40545-016-0058-6. eCollection 2016.

  PMID: 26962456 BACKGROUND

• Hepler CD. Clinical pharmacy, pharmaceutical care, and the quality of drug therapy. Pharmacotherapy. 2004 Nov;24(11):1491-8. doi: 10.1592/phco.24.16.1491.50950.

  PMID: 15537552 BACKGROUND

Study Officials

• Hiba I. Al Fahmawi, PharmD, MSc

  School of Pharmacy, The University of Jordan, Amman, Jordan

  STUDY DIRECTOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Study Director

Model Details: All patients were followed up prospectively for their length of hospital stay, and recommendations concerning each identified TRP were provided to the surgeons responsible for patients in the intervention group. Likewise, patient counseling and encouraging adherence to therapy were provided solely to patients in the intervention group. Patients in the control group received usual care by the surgical team without a coordinated contribution from the clinical pharmacist.

Study Record Dates

• First Submitted: June 8, 2021
• First Posted: June 28, 2021
• Study Start: September 29, 2019
• Primary Completion: February 6, 2020
• Study Completion: February 6, 2020
• Last Updated: June 28, 2021

Record last verified: 2021-06

Data Sharing

• IPD Sharing: Will not share

Locations

JO (1)